Status:

RECRUITING

Combination Therapy of 5-Fluorouracil and CALcipotriol Versus 5-Fluorouracil in the Treatment of Actinic Keratosis

Lead Sponsor:

Maastricht University Medical Center

Conditions:

Actinic Keratoses

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

5-Fluorouracil (5FU) is proven to be the most effective therapy in field directed treatment for AK, with Jansen et al. reporting a 1-year probability of treatment success of 74.7%. However, treatment ...

Eligibility Criteria

Inclusion

  • Adults above 18 years of age
  • Clinical and dermoscopical diagnosis of AK by a dermatologist, in one or more area(s):
  • Face, ears, (balding) scalp
  • Neck/Shawl area, including the sun-exposed chest area
  • Upper extremities
  • Number of AK lesions ≥4 in a continuous treatment area of up to 100 cm2
  • AK Olsen grade I-III

Exclusion

  • Previous field treatment for AK within 2cm of the treatment area, within 3 months
  • (non) melanoma skin cancer in treatment area
  • Mucosal lesions
  • Genetic skin cancer disorder
  • Women who are pregnant or breastfeeding
  • Women of childbearing potential, who are not willing to use effective contraceptive measures
  • Previous allergy or intolerance to either 5FU or calcipotriol
  • Patients with known contra-indications for calcipotriol use: previous diagnosis of hyper-calcemia, disturbed calcium metabolism, severe kidney or liver dysfunction
  • Concurrent use of oral capecitabine or any other topical or systemic chemopreventive agent for any indication
  • Concurrent use of other topical treatments registered as treatment for AK
  • Limited understanding of the Dutch language and not being able to give informed consent (incapacitated patients)

Key Trial Info

Start Date :

September 4 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 2 2029

Estimated Enrollment :

232 Patients enrolled

Trial Details

Trial ID

NCT06499415

Start Date

September 4 2024

End Date

March 2 2029

Last Update

May 11 2025

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Zuyderland Medical Center

Heerlen, Limburg, Netherlands, 6419 HC

2

Maastricht University Medical Center

Maastricht, Limburg, Netherlands, 6229 HX

3

VieCuri Medical Center

Venlo, Limburg, Netherlands, 5912 BL

4

Catharina Hospital Eindhoven

Eindhoven, North Brabant, Netherlands, 5623 EJ

Combination Therapy of 5-Fluorouracil and CALcipotriol Versus 5-Fluorouracil in the Treatment of Actinic Keratosis | DecenTrialz